Page 349 - Read Online

Paul J Cancer Metastasis Treat 2020;6:29 I http://dx.doi.org/10.20517/2394-4722.2020.63 Page 27 of 31

2015;95:346-58.
72. Karamanos NK, Piperigkou Z, Theocharis AD, Watanabe H, Franchi M, et al. Proteoglycan chemical diversity drives multifunctional cell
regulation and therapeutics. Chem Rev 2018;118:9152-232.
73. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell
Biol 2012;14:677-85.
74. Mu W, Rana S, Zoller M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 2013;15:875-87.
75. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, et al. Melanoma exosomes educate bone marrow progenitor cells toward
a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
76. Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 2018;75:193-208.
77. Cha DJ, Franklin JL, Dou Y, Liu Q, Higginbotham JN, et al. KRAS-dependent sorting of miRNA to exosomes. Elife 2015;4:e07197.
78. Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med 2013;274:113-26.
79. Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, et al. Osteoblasts remotely supply lung tumors with cancer-promoting
SiglecF(high) neutrophils. Science 2017;358.
80. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335-48.
81. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of
mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-60.
82. Kidd S, Spaeth E, Watson K, Burks J, Lu H, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and
bone marrow-derived stroma. PLoS One 2012;7:e30563.
83. LeBleu VS, Kalluri R. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech 2018;11.
84. Allavena P, Germano G, Mantovani A. Molecular links between inflammation and cancer. Systems Biology of Cancer: Cambridge
University Press; 2015. pp. 273-81.
85. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic
instability. Carcinogenesis 2009;30:1073-81.
86. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
87. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008;659:15-30.
88. Terlizzi M, Casolaro V, Pinto A, Sorrentino R. Inflammasome: cancer's friend or foe? Pharmacol Ther 2014;143:24-33.
89. Setrerrahmane S, Xu H. Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer 2017;16:153.
90. Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, et al. The role of interleukin 1 in growth and metastasis of human
cancer xenografts. Clin Cancer Res 2006;12:1088-96.
91. Tuomisto AE, Makinen MJ, Vayrynen JP. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic
significance. World J Gastroenterol 2019;25:4383-404.
92. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer
Cell 2016;30:836-48.
93. Manning S, Danielson KM. The immunomodulatory role of tumor-derived extracellular vesicles in colorectal cancer. Immunol Cell Biol
2018; doi: 10.1111/imcb.12038.
94. Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 2011;3:118-27.
95. Bankey PE. Hepatic reagulation of systemic inflammation following acute injury. Curr Opin Crit Care 1996;2:280-6.
96. Nieuwenhuijzen GA, Haskel Y, Lu Q, Berg RD, van Rooijen N, et al. Macrophage elimination increases bacterial translocation and gut-
origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg 1993;218:791-9.
97. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, et al. Commensal bacteria control cancer response to therapy by modulating the
tumor microenvironment. Science 2013;342:967-70.
98. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, et al. The intestinal microbiota modulates the anticancer immune effects of
cyclophosphamide. Science 2013;342:971-6.
99. Gorjifard S, Goldszmid RS. Microbiota-myeloid cell crosstalk beyond the gut. J Leukoc Biol 2016;100:865-79.
100. Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res 2013;1:150-7.
101. Rutkowski MR, Conejo-Garcia JR. TLR5 signaling, commensal microbiota and systemic tumor promoting inflammation: the three parcae
of malignant progression. Oncoimmunology 2015;4:e1021542.
102. Hui D. Prognostication of survival in patients with advanced cancer: predicting the unpredictable? Cancer Control 2015;22:489-97.
103. Wang C, Jin S, Xu S, Cao S. High systemic immune-inflammation index (SII) represents an unfavorable prognostic factor for small cell
lung cancer treated with etoposide and platinum-based chemotherapy. Lung 2020;198:405-14.
104. Dupréa A, Malika HZ. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol 2018;44:566-70.
105. Nakamura K, Smyth MJ. Targeting cancer-related inflammation in the era of immunotherapy. Immunol Cell Biol 2017;95:325-32.
106. Dinarello CA. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 2010;29:317-29.
107. Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 2015;12:584-96.
108. Chen G, Huang AC, Zhang W, Zhang G, Wu M, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-
PD-1 response. Nature 2018;560:382-6.
109. Zhou M, Chen J, Zhou L, Chen W, Ding G, et al. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells
via miR-203. Cell Immunol 2014;292:65-9.
110. Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology 2015;4:e1027472.